Aetiology and therapeutics of burning mouth syndrome: An update

Gerodontology

Volumn 29, Issue 2, 2012, Pages 84-89

  Spanemberg, Juliana Cassol ^a   Cherubini, Karen ^a   De Figueiredo, Maria Antonia Zancanaro ^a   Yurgel, Liliane Soares ^a   Salum, Fernanda Gonçalves ^a  

^a FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

Author keywords

aetiology; burning mouth syndrome; psychological profile; treatment

Indexed keywords

BENZODIAZEPINE DERIVATIVE; NEUROLEPTIC AGENT; TRANQUILIZER; TRICYCLIC ANTIDEPRESSANT AGENT;

BURNING MOUTH SYNDROME; DIFFERENTIAL DIAGNOSIS; HUMAN; PSYCHOLOGICAL ASPECT; QUALITY OF LIFE; REVIEW;

ANTIDEPRESSIVE AGENTS, TRICYCLIC; ANTIPSYCHOTIC AGENTS; BENZODIAZEPINES; BURNING MOUTH SYNDROME; DIAGNOSIS, DIFFERENTIAL; HUMANS; QUALITY OF LIFE; TRANQUILIZING AGENTS;

EID: 84861612044     PISSN: 07340664     EISSN: 17412358     Source Type: Journal    
DOI: 10.1111/j.1741-2358.2010.00384.x     Document Type: Review

References (48)

1. Danhauer SC, Miller CS, Rhodus NL, et al., Impact of criteria-based diagnosis of burning mouth syndrome on treatment outcome. J Orofac Pain 2002; 16: 305-311.
2. Femiano F, Gombos F, Scully C,. Burning mouth syndrome: open trial of psychotherapy alone, medication with alpha-lipoic acid (thioctic acid), and combination therapy. Med Oral 2004; 9: 8-13.
3. Cherubini K, Maidana JD, Weigert KL, et al. Síndrome da ardência bucal: revisão de cem casos. Rev Odonto Ciência 2005; 20: 109-113.
4. Brailo V, Vuéiaeeviae-Boras V, Alajbeg IZ, et al., Oral burning symptoms and burning mouth syndrome-significance of different variables in 150 patients. Med Oral Patol Oral Cir Bucal 2006; 11: E252-E255.
5. Salort-Llorca C, Mínguez-Serra MP, Silvestre FJ,. Drug-induced burning mouth syndrome: a new etiological diagnosis. Med Oral Patol Oral Cir Bucal 2008; 13: E167-E1670.
6. Dutrée-Meulenberg RO, Kozel MM, Van Joost T,. Burning mouth syndrome: a possible etiologic role for local contact hypersensitivity. J Am Acad Dermatol 1992; 26: 935-940.
7. Tourne LP, Fricton JR,. Burning mouth syndrome. Critical review and proposed clinical management. Oral Surg Oral Med Oral Pathol 1992; 74: 158-167.
8. Bergdahl M, Bergdahl J,. Burning mouth syndrome: prevalence and associated factors. J Oral Pathol Med 1999; 28: 350-354.
9. Evans RW, Drage LA,. Burning mouth syndrome. Headache 2005; 45: 1079-1081.
10. Gao J, Chen L, Zhou J, et al., A case-control study on etiological factors involved in patients with burning mouth syndrome. J Oral Pathol Med 2009; 38: 24-8.
11. Bergdahl M, Bergdahl J,. Low unstimulated salivary flow and subjective oral dryness: association with medication, anxiety, depression, and stress. J Dent Res 2000; 79: 1652-1658.
12. Soares MS, Chimenos-Küstner E, Subirá-Pifarrè C, et al., Association of burning mouth syndrome with xerostomia and medicines. Med Oral Patol Oral Cir Bucal 2005; 10: 301-308.
13. Ito M, Kurita K, Ito T, et al., Pain threshold and pain recovery after experimental stimulation in patients with burning mouth syndrome. Psychiat Clin Neurosci 2002; 56: 161-168.
14. Suh KI, Lee JY, Chung JW, et al., Relationship between salivary flow rate and clinical symptoms and behaviours in patients with dry mouth. J Oral Rehab 2007; 34: 739-744.
15. Cavalcanti DR, Silveira FRX,. Alpha lipoic acid in burning mouth syndrome-a randomized double-blind placebo-controlled trial. J Oral Pathol Med 2009; 38: 254-261.
16. López-Jornet P, Camacho-Alonso F, Lucero-Berdugo M,. Quality of life in patients with burning mouth syndrome. J Oral Pathol Med 2008; 37: 389-394.
17. Ship JA, Grushka M, Lipton JA, et al., Burning mouth syndrome: an update. J Am Dent Assoc 1995; 126: 842-853.
18. Scala A, Checchi L, Montevecchi M, et al., Update on burning mouth syndrome: overview and patient management. Crit Rev Oral Biol Med 2003; 14: 275-291.
19. Dias Fernandes CS, Salum FG, Bandeira D, et al., Salivary dehydroepiandrosterone (DHEA) levels in patients with the complaint of burning mouth: a case-control study. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2009; 108: 537-543.
20. Forabosco A, Criscuol M, Coukos G, et al., Efficacy of hormone replacement therapy in postmenopausal women with oral discomfort. Oral Surg Oral Med Oral Pathol 1992; 73: 570-574.
21. Lauria G, Majorana A, Borgna M, et al., Trigeminal small-fiber sensory neuropathy causes burning mouth syndrome. Pain 2005; 115: 327-332.
22. Albuquerque RJC, Leeuw R, Carlson CR, et al., Cerebral activation during thermal stimulation of patients who have burning mouth disorder: an fMRI study. Pain 2006; 122: 223-234.
23. Pokupec-Gruden JS, Cekic-Arambasin A, Gruden V,. Psychogenic factors in the aetiology of stomatopyrosis. Coll Antropol 2000; 24: 119-126.
24. Abetz LM, Savage NW,. Burning mouth syndrome and psychological disorders. Aust Dent J 2009; 54: 84-93.
25. Grushka M, Epstein JB, Gorsky M,. Burning mouth syndrome. Am Fam Physician 2002; 65: 615-620.
26. Meurman JH, Tarkkila L, Tiitinen A,. The menopause and oral health. Maturitas 2009; 63: 56-62.
27. Wardrop RW, Hailes J, Burger H, et al., Oral discomfort at menopause. Oral Surg Oral Med Oral Pathol 1989; 67: 535-540.
28. Tarkkila L, Linna M, Tiitinen A, et al., Oral symptoms at menopause-the role of hormone replacement therapy. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2001; 92: 276-280.
29. Femiano F, Gombos F, Scully C, et al., Burning mouth syndrome (BMS): controlled open trial of the efficacy of alpha-lipoic acid (thioctic acid) on symptomatology. Oral Dis 2000; 6: 274-277.
30. Femiano F, Scully C,. Burning mouth syndrome (BMS): double blind controlled study of alpha-lipoic acid (thioctic acid) therapy. J Oral Pathol Med 2002; 31: 267-269.
31. Yilmaz Z, Renton T, Yiangou Y, et al., Burning mouth syndrome as a trigeminal small fibre neuropathy: increased heat and capsaicin receptor TRPV1 in nerve fibres correlates with pain score. J Clin Neurosci 2007; 14: 864-871.
32. Guimarães ALS, Sá AR, Victoria JMN, et al., Interleukin-1β and serotonin transporter gene polymorphisms in burning mouth syndrome patients. Pain 2006; 7: 654-658.
33. Guarneri F, Guarneri C, Marini H,. Contribution of neuroinflammation in burning mouth syndrome: indications from benzodiazepine use. Dermatol Ther 2008; 21: 21-24.
34. Amenábar JM, Pawlowski J, Hilgert J, et al., Anxiety and salivary cortisol levels in patients with burning mouth syndrome: case-control study. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2008; 105: 460-465.
35. Palacios-Sánchez MF, Jordana-Comín X, García-Sivoli CE,. Burning mouth syndrome: a retrospective study of 140 cases in a sample of Catalan population. Med Oral Patol Oral Cir Bucal 2005; 10: 388-393.
36. Epstein JB, Marcoe JH,. Topical application of capsaicin for treatment of oral neuropathic pain and trigeminal neuralgia. Oral Surg Oral Med Oral Pathol 1994; 77: 135-140.
37. Winocur E, Gavish A, Halachmi M, et al., Topical application of capsaicin for the treatment of localized pain in the temporomandibular joint area. J Orofac Pain 2000; 14: 31-36.
38. Espinosa LS, López JP, Frutos RR,. Síndrome de boca ardiente. Eficacia de la aplicación tópica de capsaicina. Estudio Piloto Av Odontoestomatol 2004; 20: 297-304.
39. Mínguez-Serra MP, Salort-Llorca C, Silvestre-Donat FJ,. Pharmacological treatment of burning mouth syndrome: a review and update. Med Oral Patol Oral Cir Bucal 2007; 12: E299-E304.
40. Gremeau-Richard C, Woda A, Navez ML, et al., Topical clonazepam in stomatodynia: a randomised placebo-controlled study. Pain 2004; 108: 51-57.
41. Yamazaki Y, Hata H, Kitamori S, et al., An open-label, noncomparative, dose escalation pilot study of the effect of paroxetine in treatment of burning mouth syndrome. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2009; 107: e6. 11.
42. Ueda N, Kodama Y, Hori H, et al., Two cases of burning mouth syndrome treated with olanzapine. Psychiat Clin Neurosci 2008; 62: 359-361.
43. Tammiala-Salonen T, Forssell H,. Trazodone in burning mouth pain: a placebo-controlled, double-blind study. J Orofac Pain 1999; 13: 83-88.
44. Sheehan DV, Croft HA, Gossen ER, et al., Extended-release trazodone in major depressive disorder: a randomized, double-blind, placebo-controlled study. Psychiatry 2009; 6: 20-33.
45. Bergdahl J, Anneroth G, Perris H,. Personality characteristics of patients with resistant burning mouth syndrome. Acta Odontol Scand 1995; 53: 7-11.
46. Carbone M, Pentenero M, Carrozzo M, et al., Lack of efficacy of alpha-lipoic acid in burning mouth syndrome: a double-blind, randomized, placebo-controlled study. Eur J Pain 2008; 13: 492-496.
47. López-Jornet P, Camacho-Alonso F, Leon-Espinosa S,. Efficacy of alpha lipoic acid in burning mouth syndrome: a randomized, placebo-treatment study. J Oral Rehabil 2009; 36: 52-57.
48. Sardella A, Uglietti D, Demarosi F, et al., Benzydamine hydrochloride oral rinses in management of burning mouth syndrome. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1999; 88: 683-686.